Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Caenorhabditis elegans as an emerging high throughput chronotherapeutic drug screening platform for human neurodegenerative disorders

17 Jul 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circadian rhythm and melatonin
Share to Genetics, Aging, and Longevity in Model Organisms
Share to Spaceflight effects on biology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40683385
DOI: 10.1016/j.addr.2025.115655

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Caenorhabditis elegans as an emerging high throughput chronotherapeutic drug screening platform for human neurodegenerative disordersPMID 40683385Read ↗

Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseasesSemantic proximity Read ↗

Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeuticsSemantic proximity Read ↗

Systematic Review of Caenorhabditis elegans Models for Mechanism Research and Drug Discovery in Parkinson’s DiseaseSemantic proximity Read ↗

Caenorhabditis elegans as a Model System to Study Human Neurodegenerative DisordersSemantic proximity Read ↗

Drug discovery: Insights from the invertebrate Caenorhabditis elegansSemantic proximity Read ↗

Caenorhabditis elegans as a model for exploring the efficacy of synthesized organoruthenium complexes for aging and Alzheimer's disease a neurodegenerative disorder: A systematic approachSemantic proximity Read ↗

C. elegans, a model for aging with high-throughput capacity.Semantic proximity Read ↗

Drug repurposing for aging research using model organismsSemantic proximity Read ↗

Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson’s disease, Alzheimer’s disease and autism spectrum disorderSemantic proximity Read ↗

Towards Understanding Neurodegenerative Diseases: Insights from Caenorhabditis elegansSemantic proximity Read ↗

NIA Caenorhabditis Intervention Testing Program: identification of robust and reproducible pharmacological interventions that promote longevity across experimentally accessible, genetically diverse populations.Semantic proximity Read ↗

Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and HealthspanSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.